This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

Catheter ablation is associated with better outcomes for AFib patients, researchers noted, but beginning treatment with just antiarrhythmic medications may be the most practical option. 

The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time. 

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

Heart patients exposed to phthalates—a group of chemicals used as plasticizers in the manufacture of plastic medical products—during invasive procedures may be at risk for serious electrophysiological abnormalities, according to a new study.